Weight Loss Without Ozempic: Why Compounded Tirzepatide Gets Better Results for Less
Quick Answer
Ozempic is a brand-name semaglutide for diabetes, not FDA-approved for weight loss (Wegovy is). Compounded tirzepatide produces 21% average weight loss vs semaglutide's 15%, costs $339/mo vs $1,400+ brand-name, and is available through telehealth without insurance.
Ozempic vs weight loss medications explained
Ozempic is semaglutide prescribed for type 2 diabetes. It's made by Novo Nordisk and dosed at up to 2mg weekly. While physicians sometimes prescribe it off-label for weight loss, it is not FDA-approved for that purpose. The weight-loss-approved version of semaglutide is Wegovy, which goes up to 2.4mg weekly.
This distinction matters because when people search for “weight loss without Ozempic,” they often mean they want an alternative to the brand-name pricing and insurance hoops — not necessarily an alternative to the drug class itself. GLP-1 receptor agonists remain one of the most effective pharmacological tools for weight loss ever developed. The question is which one, and how to access it affordably.
There are now two major GLP-1 options: semaglutide (single GLP-1 agonist) and tirzepatide (dual GIP/GLP-1 agonist). Both are available as compounded formulations through Marrow at a fraction of brand-name cost.
Tirzepatide: the superior alternative (SURMOUNT-1 data)
The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, enrolled 2,539 adults with obesity. Participants on the highest dose of tirzepatide (15mg weekly) lost an average of 22.5% of their body weight over 72 weeks. At the mid-range 10mg dose, average loss was 21.4%. Even the lowest 5mg dose produced 15% weight loss — matching semaglutide's best result.
Why does tirzepatide outperform semaglutide? It targets two receptors instead of one. Semaglutide activates only the GLP-1 receptor, which reduces appetite and slows gastric emptying. Tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, which enhances insulin sensitivity, improves fat metabolism, and produces greater appetite suppression.
| Metric | Tirzepatide (SURMOUNT-1) | Semaglutide (STEP 1) |
|---|---|---|
| Avg weight loss | 22.5% | 14.9% |
| Mechanism | Dual GIP/GLP-1 | GLP-1 only |
| Trial duration | 72 weeks | 68 weeks |
| Brand-name cost | $1,000-1,400/mo | $900-1,200/mo |
| Marrow compounded | $339/mo | $249/mo |
Compounded GLP-1 options and how they work
Compounding pharmacies are FDA-registered facilities that prepare medications using the same active pharmaceutical ingredients as brand-name drugs. 503B compounding pharmacies operate under federal oversight, follow Current Good Manufacturing Practice (cGMP) guidelines, and undergo regular FDA inspections. Every batch is tested for potency and purity.
Compounded GLP-1 medications remove the brand-name markup while delivering the same active ingredient. At Marrow, compounded tirzepatide starts at $339/mo and compounded semaglutide starts at $249/mo. Both include physician oversight, injection supplies, dosage adjustments, and free shipping. No insurance required.
This is the real “Ozempic alternative” most people are looking for — not a different drug class, but the same proven medications at an accessible price, with genuine medical oversight built in.
Semaglutide is still great — just not via the Ozempic brand
If tirzepatide isn't the right fit — whether due to tolerability, physician recommendation, or personal preference — compounded semaglutide remains an excellent option. The STEP 1 trial demonstrated 14.9% average body weight reduction over 68 weeks. That's roughly 34 pounds for someone starting at 230 pounds.
The key difference is access and cost. Brand-name Wegovy runs $900-1,200/month without insurance. Brand-name Ozempic (off-label for weight loss) is similarly priced. Compounded semaglutide through Marrow is $249/month — same active ingredient, same mechanism, fraction of the price.
Compare the options in detail on our semaglutide vs Ozempic page, or view full pricing details.
How to get started
Complete your intake
A quick 5-minute questionnaire about your health history, current medications, and weight loss goals.
Physician review within 24 hours
A licensed physician reviews your intake and determines whether tirzepatide or semaglutide is the best fit for you.
Medication ships to your door
Your prescription is compounded by an FDA-registered pharmacy and shipped with all supplies in 3-5 business days.
Frequently asked questions
Why shouldn't I just get Ozempic for weight loss?
Ozempic is FDA-approved for type 2 diabetes, not weight loss. The weight-loss-approved version of semaglutide is Wegovy. More importantly, tirzepatide (the dual GIP/GLP-1 agonist) has shown superior weight loss results in head-to-head comparisons. Compounded tirzepatide at Marrow costs $339/mo vs $1,400+/mo for brand-name Mounjaro or Zepbound.
How much weight can I lose with compounded tirzepatide?
In the SURMOUNT-1 clinical trial, participants on the highest dose of tirzepatide lost an average of 22.5% of their body weight over 72 weeks. That's roughly 50 pounds for someone starting at 230 pounds. Results vary by individual, but tirzepatide consistently outperforms semaglutide in clinical data.
Is compounded tirzepatide safe?
Yes. Compounded tirzepatide uses the same active pharmaceutical ingredient as Mounjaro and Zepbound. It's prepared by FDA-registered 503B compounding pharmacies under strict quality controls, including batch testing for potency and purity. Your Marrow physician monitors you throughout treatment.
What's the difference between semaglutide and tirzepatide?
Semaglutide targets the GLP-1 receptor only. Tirzepatide targets both GLP-1 and GIP receptors, which is why clinical trials show greater weight loss (21% vs 15% average body weight reduction). Both are effective — tirzepatide simply has a dual mechanism of action that produces stronger results for most patients.
Do I need insurance to get compounded GLP-1 medication?
No. Marrow operates on a direct-pay model. Compounded tirzepatide is $339/mo and compounded semaglutide is $249/mo — no insurance required. This is often cheaper than brand-name copays even with insurance.
Can I switch from Ozempic to compounded tirzepatide?
Yes. Many Marrow patients switch from semaglutide (including Ozempic or Wegovy) to tirzepatide for better results. Your physician will create a transition plan that accounts for your current dose and adjusts accordingly to minimize side effects.
How do I get started with Marrow?
Complete a 5-minute online intake at marrowrx.com/start. A licensed physician reviews your health history within 24 hours and, if appropriate, prescribes your medication. It ships from an FDA-registered pharmacy within 3-5 business days.
Start compounded tirzepatide for $339/mo
5-minute intake. Physician review within 24 hours. Ships to your door.
Start your intake →